User profiles for Nicolas Beaume

Nicolas Beaume

Verified email at braininsilico.com
Cited by 596

[HTML][HTML] Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant

…, A Gustin, C Birck, M Kirchmeyer, N Beaume… - PloS one, 2016 - journals.plos.org
Parkinson’s disease (PD) is histologically described by the deposition of α-synuclein, whose
accumulation in Lewy bodies causes dopaminergic neuronal death. Although most of PD …

Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNA-mediated …

N Beaume, R Pathak, VK Yadav, S Kota… - Nucleic acids …, 2013 - academic.oup.com
A remarkable number of guanine-rich sequences with potential to adopt non-canonical
secondary structures called G-quadruplexes (or G4 DNA) are found within gene promoters. …

[HTML][HTML] Regulation of neutrophil degranulation and cytokine secretion: a novel model approach based on linear fitting

I Naegelen, N Beaume, S Plançon… - Journal of immunology …, 2015 - hindawi.com
Neutrophils participate in the maintenance of host integrity by releasing various cytotoxic
proteins during degranulation. Due to recent advances, a major role has been attributed to …

[HTML][HTML] Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

C Margue, S Reinsbach, D Philippidou, N Beaume… - Oncotarget, 2015 - ncbi.nlm.nih.gov
MiRNAs are increasingly recognized as biomarkers for the diagnosis of cancers where they
are profiled from tumor tissue (intracellular miRNAs) or serum/plasma samples (extracellular …

[HTML][HTML] Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

E Letellier, M Schmitz, K Baig, N Beaume… - British journal of …, 2014 - nature.com
Background: Over the past years, some members of the family of suppressor of cytokine
signalling (SOCS) proteins have emerged as potential tumour suppressors. This study aimed at …

[HTML][HTML] Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

…, AS Woodward Davis, N Beaume… - PLoS …, 2023 - journals.plos.org
The VRC01 Antibody Mediated Prevention (AMP) efficacy trials conducted between 2016 and
2020 showed for the first time that passively administered broadly neutralizing antibodies (…

[PDF][PDF] Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISH

…, B Dartigues, JH Warrell, MR Pimentel, N Beaume… - Cell Reports …, 2021 - cell.com
Advances in single-cell RNA sequencing have allowed for the identification of cellular
subtypes on the basis of quantification of the number of transcripts in each cell. However, cells …

[PDF][PDF] Prediction of RNA subcellular localization: learning from heterogeneous data sources

AF Savulescu, E Bouilhol, N Beaume, M Nikolski - Iscience, 2021 - cell.com
RNA subcellular localization has recently emerged as a widespread phenomenon, which
may apply to the majority of RNAs. The two main sources of data for characterization of RNA …

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

…, A Yssel, D Matten, T York, N Beaume… - Proceedings of the …, 2024 - National Acad Sciences
In the Antibody Mediated Prevention (AMP) trials (HVTN 704/HPTN 085 and HVTN 703/HPTN
081), prevention efficacy (PE) of the monoclonal broadly neutralizing antibody (bnAb) …

[PDF][PDF] Rice Galaxy: an open resource for plant science

V Juanillas, A Dereeper, N Beaume, G Droc… - …, 2019 - academic.oup.com
Background Rice molecular genetics, breeding, genetic diversity, and allied research (such
as rice-pathogen interaction) have adopted sequencing technologies and high-density …